Gustavo Westin is an Oncology physician. OpenAlex indexes 32 publications with 262 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8981 Colonial Center Dr
Fort Myers, FL 339057816
Telephone
239-938-0800Provider last certified this registry record 10 Sept 2024.
Industry payments
77 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202514 payments
- AstraZeneca Pharmaceuticals LPProgram year202511 payments
- Celgene CorporationProgram year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
38.1%CD38-directed Cytolytic Antibody27.2%Daratumumab100%Part B, office-administered≥13 patientsPD-1 inhibitor10.5%Pembrolizumab100%Part B, office-administered≥11 patients+ 5 more classes in this area
Musculoskeletal
36.9%Other drugs affecting bone structure and mineralization23.2%Romosozumab-aqqg100%Part B, office-administered≥12 patientsRANK Ligand Inhibitor13.5%Denosumab99%Xgeva0%Prolia0%Part D + Part B<11 patients+ 1 more class in this area
Blood & clotting
18.5%Iron, parenteral preparations11.3%Ferric derisomaltose100%Part B, office-administered≥32 patientsErythropoiesis-stimulating Agent6.9%Epoetin alfa95%Procrit5%Part D + Part B≥21 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”